HRP20140135T1 - Sastavi polietilen glikola za kontrolu recidiva herpesa labialis, herpesa genitalis i herpesa zoster - Google Patents

Sastavi polietilen glikola za kontrolu recidiva herpesa labialis, herpesa genitalis i herpesa zoster Download PDF

Info

Publication number
HRP20140135T1
HRP20140135T1 HRP20140135AT HRP20140135T HRP20140135T1 HR P20140135 T1 HRP20140135 T1 HR P20140135T1 HR P20140135A T HRP20140135A T HR P20140135AT HR P20140135 T HRP20140135 T HR P20140135T HR P20140135 T1 HRP20140135 T1 HR P20140135T1
Authority
HR
Croatia
Prior art keywords
polyethylene glycol
topical application
lips
recurrence
day
Prior art date
Application number
HRP20140135AT
Other languages
English (en)
Croatian (hr)
Inventor
Peter Vitins
Marcel Langenauer
Paul Martin Scherer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of HRP20140135T1 publication Critical patent/HRP20140135T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20140135AT 2010-07-08 2011-07-08 Sastavi polietilen glikola za kontrolu recidiva herpesa labialis, herpesa genitalis i herpesa zoster HRP20140135T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (1)

Publication Number Publication Date
HRP20140135T1 true HRP20140135T1 (hr) 2014-03-28

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140135AT HRP20140135T1 (hr) 2010-07-08 2011-07-08 Sastavi polietilen glikola za kontrolu recidiva herpesa labialis, herpesa genitalis i herpesa zoster

Country Status (20)

Country Link
US (2) US9814743B2 (OSRAM)
EP (1) EP2563374B1 (OSRAM)
JP (1) JP5858994B2 (OSRAM)
KR (1) KR101881175B1 (OSRAM)
CN (1) CN103079574B (OSRAM)
AU (1) AU2011275458B2 (OSRAM)
CA (1) CA2803228C (OSRAM)
DK (1) DK2563374T3 (OSRAM)
ES (1) ES2442928T3 (OSRAM)
HR (1) HRP20140135T1 (OSRAM)
IL (1) IL223582A (OSRAM)
MX (1) MX2012014783A (OSRAM)
PL (1) PL2563374T3 (OSRAM)
PT (1) PT2563374E (OSRAM)
RS (1) RS53162B (OSRAM)
RU (1) RU2643763C2 (OSRAM)
SG (1) SG186937A1 (OSRAM)
SI (1) SI2563374T1 (OSRAM)
WO (1) WO2012004669A1 (OSRAM)
ZA (1) ZA201300177B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53162B (sr) 2010-07-08 2014-06-30 Devirex Ag Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2014130432A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
UY37497A (es) * 2016-11-28 2018-06-29 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
EP3962924A1 (en) 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
WO2021233571A1 (de) * 2020-04-30 2021-11-25 Ninoderm Ug (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) * 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
EP2121027A2 (en) 2007-01-17 2009-11-25 Devirex AG Cyclodextrin formulations
RS53162B (sr) 2010-07-08 2014-06-30 Devirex Ag Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
CA2803228A1 (en) 2012-01-12
ZA201300177B (en) 2014-03-26
US20130090389A1 (en) 2013-04-11
JP5858994B2 (ja) 2016-02-10
AU2011275458B2 (en) 2014-11-27
MX2012014783A (es) 2013-04-03
AU2011275458A1 (en) 2013-02-28
RS53162B (sr) 2014-06-30
RU2013100383A (ru) 2014-08-20
WO2012004669A1 (en) 2012-01-12
RU2643763C2 (ru) 2018-02-05
EP2563374A1 (en) 2013-03-06
HK1180969A1 (en) 2013-11-01
IL223582A (en) 2017-12-31
DK2563374T3 (da) 2014-01-20
EP2563374B1 (en) 2013-11-13
PT2563374E (pt) 2014-01-23
CN103079574B (zh) 2017-04-12
PL2563374T3 (pl) 2014-04-30
JP2013530208A (ja) 2013-07-25
CN103079574A (zh) 2013-05-01
SI2563374T1 (sl) 2014-01-31
CA2803228C (en) 2019-03-12
KR101881175B1 (ko) 2018-07-23
US9814743B2 (en) 2017-11-14
ES2442928T3 (es) 2014-02-14
SG186937A1 (en) 2013-02-28
US20180055875A1 (en) 2018-03-01
KR20130142992A (ko) 2013-12-30

Similar Documents

Publication Publication Date Title
HRP20140135T1 (hr) Sastavi polietilen glikola za kontrolu recidiva herpesa labialis, herpesa genitalis i herpesa zoster
HRP20210352T1 (hr) Terapeutska sredstva za liječenje bolesti povezanih s neželjenom proliferacijom stanica
EP2555620A4 (en) Sophorolipid ANALOG COMPOSITIONS
MX355294B (es) Artículos para el cuidado personal que tienen composiciones para el cuidado personal que tienen múltiples zonas amoldables.
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
HRP20251174T1 (hr) Postupci za liječenje psorijatičnog artritisa uporabom il-17 antagonista
EA200900046A1 (ru) Слабо пенящиеся композиции для защиты растений
GT200500230A (es) Nuevas composiciones farmacèuticas para el tratamiento de trastornos hiperproliferativos
MX366159B (es) Liberacion autorregulada de ingrediente farmaceutico activo.
GEP20104994B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
MX2022013590A (es) Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
AR053549A1 (es) Composicion y metodo para mejorar la salud de plantas
CO6620043A2 (es) Procedimiento de preparación de composiciones famacéuticas destinadas a la administración por vía oral que comprende uno o varios principios activos y las composiciones que las comprenden
HK1201828A1 (en) Treatment regimens using multiple pharmaceutical agents
BR112015015864A8 (pt) composição farmacêutica, e, uso de uma composição farmacêutica
PH12014501038B1 (en) Pharmaceutical composition useful for adhesion prevention or hemostasis
BRPI0720118B8 (pt) forma sólida de dosagem farmacêutica para administração oral compreendendo cloridrato de valganciclovir
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
ATE516041T1 (de) Synergistische zusammensetzungen mit fk-228
HRP20240166T1 (hr) Postupak liječenja prader-willijevog sindroma
JP2013530208A5 (OSRAM)
WO2012135528A3 (en) Galectin-3c combination therapy for human cancer
MX2011010547A (es) Composiciones farmaceuticas estables de diclofenaco.
BR112015014092A2 (pt) administração oral transmucosal de acetato de glatirâmer
BRPI0511066A (pt) compostos tipo leptomicina, composição farmacêutica compreendendo os mesmos e usos